MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

|
For the year ending 2025-06-30, ANEB made $739,913 in revenue. -$8,484,763 in net income. Net profit margin of -1146.72%.

Income Overview

Revenue
$739,913
Net Income
-$8,484,763
Net Profit Margin
-1146.72%
EPS
-$0.25
Unit: Dollar
Revenue Breakdown
    • Grant income
    • Interest expense
    • Interest income

Unit: Dollar
Income Statement
2025-06-30
Research and development4,299,941
General and administrative4,923,540
Total operating expenses-9,223,481
Loss from operations-9,223,481
Other-1,195
Interest income257,913
Interest expense-382,014
Grant income864,014
Other income, net738,718
Net loss-8,484,763
Net loss per share, basic-0.25
Net loss per share, diluted-0.25
Weighted average common shares outstanding, basic33,820,306
Weighted average common shares outstanding, diluted33,820,306
Unit: Dollar

Income Statement

DownloadDownload image
Grant income$864,014 Interest income$257,913 Net loss-$8,484,763 Other income, net$738,718 Interest expense$382,014 Other-$1,195 Loss from operations-$9,223,481 Total operatingexpenses$9,223,481 General andadministrative$4,923,540 Research and development$4,299,941

Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals, Inc. (ANEB)